Καινοτομία

To mark the European Month of the Brain, we look at one EU-funded project that has focussed efforts on drug delivery across the so-called blood-brain barrier.

The blood-brain barrier (BBB), while preforming a key protective function, is now recognised as the major obstacle in the treatment of most neurological disorders. It hinders the delivery of many potentially important therapeutic and diagnostic substances to the central nervous system (CNS).